Atorvastatin Calcium
Product Images NDC 68071-2465

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure diagram showing the molecular formula for Atorvastatin Calcium as a dihydrate salt, including its complex ring structures with phenyl groups, fluorine atom, hydroxyl groups, and calcium ions indicated as Ca2+ with 3 water molecules (3H2O).*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A line chart depicting cumulative incidence percentages over 3.5 years for Atorvastatin versus Placebo. The graph shows two lines, one solid for Atorvastatin and one dashed for Placebo, indicating lower cumulative incidence with Atorvastatin. The chart includes a hazard ratio and p-value comparison between the two groups.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A line graph comparing cumulative hazard percentages over time between Placebo and Atorvastatin groups. The x-axis indicates years of follow-up up to 5 years, and the y-axis shows cumulative hazard percentage up to 15%. The graph includes a hazard ratio (HR) of 0.63 with confidence intervals (0.48-0.83) and p-value (p=0.001).*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph showing the percentage of subjects experiencing the first major cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg doses. The graph compares the time to event between the two dosage groups with a hazard ratio (HR) of 0.78 and a p-value of 0.0002, indicating a difference in event rates over time.*
FDA Label Image

Pdp (68071 2465 9)

Pdp (68071 2465 9)
Atorvastatin Calcium 80mg tablets, packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The label indicates a 90 tablet count and is marked Rx Only. It includes storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children. The label also notes the product is manufactured by Lupin Limited, India, with various barcodes and batch details visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.